TFR2 and acute myeloid leukemia: In bone marrow specimens from AML and MDS patients, however, the researchers found that high TFR2 mRNA expression had a relatively favorable prognosis, suggesting that TRF2 may alter iron metabolism and increase AML cell sensitivity to chemotherapy (Nakamaki et al., 2004; Di Savino et al., 2017).